Skip to main content

Three Quotes About an Unprecedented Year

When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.


Last week, CSL announced its earnings for the previous fiscal year, virtually of course. It was a chance to bring together employees across the globe to both reflect and shift to what’s next.

Senior Vice President, R&D Strategic Operations, Deirdre BeVard

BeVard gave an overview of R&D work and noted the collaboration shown during CSL’s response to COVID-19. The company is working on multiple projects related to treating and preventing the novel coronavirus.

Deidre BeVard says: We get to see our values lived every day.

Noemi Lattanzio, Regulatory Scientist and leader of CSL Behring’s STEM program

Despite COVID-19, Lattanzio said CSL Behring employees at the King of Prussia, Pennsylvania, campus continued to support area students through the Young Men and Women in Charge foundation. Virtual events have included mock interviews and virtual job shadowing and this outreach will continue in 2021, she said.

Girl looking into microscope: STEM program continues despite COVID-19

CSL Limited CEO Paul Perreault

Perreault gave a positive report on the most recent fiscal year. Despite COVID-19 challenges, the future looks bright, he said. CSL, with accomplished businesses in plasma-derived medicines and influenza vaccines, has specific expertise to address the current public health crisis.

Paul Perreault says: Our reason for being has never been stronger.